NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
Clinical trial NCT00248404 · COMPLETED
Trial details
- NCT number
- NCT00248404
- Sponsor
- Kiadis Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-12-12
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.